Selumetinib Treatment for Pediatric Patients in the United States (US) with Neurofibromatosis Type 1 (NF1) with Plexiform Neurofibromas (PN): A Retrospective Cohort Study; D134BR00002

Project: Research project

Project Details

Description

Selumetinib Treatment for Pediatric Patients in the United States (US) with Neurofibromatosis Type 1 (NF1) with Plexiform Neurofibromas (PN): A Retrospective Cohort Study; D134BR00002
StatusActive
Effective start/end date10/23/2410/22/35

Funding

  • ALEXION PHARMACEUTICALS

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.